Company / Interest Expense
10x Genomics, Inc. Interest Expense History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$33.0K
FY2023
5-year range
$33.0K / $866.0K
FY2019-FY2023
Trend
-93.1%
vs FY2022
Sector context
#41 of 40
Health Care
What the data says
Among 40 Health Care companies, 10x Genomics, Inc. is in the top -2% for interest expense. Interest Expense has declined for 4 consecutive years, from $3M in FY2019 to $33,000 in FY2023.
Based on SEC 10-K filings.
$33,000 in FY2023 with a 5-year CAGR of -57.6%.
Improved from $866,000 to $33,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -73.0%
- 5-Year CAGR
- -57.6%
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 40This company $33.0K Sector average $332.7M
▼
-100.0% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s interest expense has declined for 4 consecutive years.
- 5-year CAGR of -57.6%, indicating a declining trend.
- In FY2023, interest expense decreased 93.1% year-over-year.
- Ranks #41 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $33.0K | -93.1% |
| FY2022 | $476.0K | -45.0% |
| FY2021 | $866.0K | -48.5% |
| FY2020 | $1.7M | -45.4% |
| FY2019 | $3.1M | +27.8% |
| FY2018 | $2.4M | +197.0% |
| FY2017 | $811.0K | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026